There is a tremendous amount of frustration with the current state of rare and orphan drug development. With over 7,000 rare diseases, only 344 therapies & treatments have been developed over 25+ years and the passing of the Orphan Drug Act of 1983.
What have been the road blocks and what is the community currently doing to accelerate drug development.
Here is a  perspective from a rare disease parent advocate on this ongoing debate: